BioPharmX Corp Contracts & Agreements
144 Contracts & Agreements
- Business Finance (94 contracts)
- Business Operations (7)
- Human Resources (12)
- Intellectual Property (1)
- Mergers & Acquisitions (4)
- Real Estate (6)
- Uncategorized (20)
- Asset Purchase Agreement, dated November 17, 2023, by and among the Company, Timber Pharmaceuticals, LLC, BioPharmX, Inc., LEO Pharma, A/S and LEO Spiny Merger Sub, Inc (Filed With SEC on November 17, 2023)
- Form of DIP Credit Agreement, to be entered intoby the Company, Timber Pharmaceuticals, LLC, BioPharmX, Inc. and LEO USHolding, Inc (Filed With SEC on November 17, 2023)
- Engagement Letter, dated October 31, 2023, by and between the Company and VRS Restructuring, LLC (Filed With SEC on November 17, 2023)
- Form of Retention Bonus Agreement, dated November 14, 2023 (Filed With SEC on November 17, 2023)
- First Amendment to Secured Bridge Loan Agreement, dated October 27, 2023, by and among Timber Pharmaceuticals, Inc., Timber Pharmaceuticals, LLC, BioPharmX, Inc. and LEO US... (Filed With SEC on October 30, 2023)
- Secured Bridge Loan Agreement, dated August 30, 2023, by and among Timber Pharmaceuticals, Inc., Timber Pharmaceuticals, LLC, BioPharmX, Inc. and LEO US Holding, Inc (Filed With SEC on August 31, 2023)
- Form of Warrant Amendment (Filed With SEC on August 31, 2023)
- Agreement and Plan of Merger, dated August 20, 2023, by and among Timber Pharmaceuticals, Inc., LEO US Holding, Inc., Leo Spiny Merger Sub, Inc. and LEO Pharma A/S (Filed With SEC on August 21, 2023)
- Amendment No. 2 to Asset Acquisition Agreement, dated August 20, 2023, by and among Timber Pharmaceuticals LLC, Patagonia Pharmaceuticals LLC, Johnathan Rome and Zachary Rome (Filed With SEC on August 21, 2023)
- Lease Agreement, dated February 8, 2023, by and between Timber Pharmaceuticals, Inc. and Paulus, Sokolowski and Sartor, LLC (Filed With SEC on March 31, 2023)
- Form of Series 1 Warrant (Filed With SEC on October 3, 2022)
- Form of Series 2 Warrant (Filed With SEC on October 3, 2022)
- Form of Securities Purchase Agreement, dated October 3, 2022, by and among Timber Pharmaceuticals, Inc. and the purchaser signatories thereto (Filed With SEC on October 3, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 8, 2022)
- Form of Common Warrant (Filed With SEC on August 8, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 2, 2022)
- Letter Agreement, dated July 27, 2022, between Timber Pharmaceuticals, Inc. and TardiMed Sciences LLC (Filed With SEC on August 2, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 2, 2022)
- Form of Common Warrant (Filed With SEC on August 2, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on August 2, 2022)
- Amendment No. 1 to the Asset Acquisition Agreement, dated July 20, 2022, by and among Timber Pharmaceuticals LLC, Patagonia, Jonathan Rome and Zachary Rome (Filed With SEC on July 26, 2022)
- Underwriting Agreement, dated November 2, 2021 by and between Timber Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on November 4, 2021)
- Form of Pre-funded Warrant (Filed With SEC on November 4, 2021)
- Form of Warrant (Filed With SEC on November 4, 2021)
- Description of Capital Stock (Filed With SEC on March 23, 2021)
- Timber Pharmaceuticals, Inc. 2020 Omnibus Equity Incentive Plan (Filed With SEC on March 23, 2021)
- Form of Incentive Stock Option Grant Agreement (Filed With SEC on March 23, 2021)
- Form of Nonqualified Stock Option Grant Agreement (Filed With SEC on March 23, 2021)
- Form of Restricted Stock Unit Award Agreement (Filed With SEC on March 23, 2021)
- Form of Restricted Stock Award Agreement (Filed With SEC on March 23, 2021)
- Lease Agreement, effective as of March 10, 2021, by and between Timber Pharmaceuticals, Inc. and SIG 110 LLC (Filed With SEC on March 16, 2021)
- Offer Letter, dated January 19, 2021, between the Company and Alan Mendelsohn, M.D (Filed With SEC on January 25, 2021)
- Form of Waiver Agreement, dated as of November 19, 2020, by and between Timber Pharmaceuticals, Inc. and the Holders (Filed With SEC on November 20, 2020)
- Amended and Restated Registration Rights Agreement, dated July 17, 2020, by and between Timber Pharmaceuticals, Inc. and certain buyers named therein (Filed With SEC on August 18, 2020)
- Form of A Warrant (Filed With SEC on June 3, 2020)
- Form of B Warrant (Filed With SEC on June 3, 2020)
- Offer Letter, dated March 31, 2020, between Zachary Rome and Timber Sub (Filed With SEC on May 22, 2020)
- Offer Letter, dated March 31, 2020, between Michael Derby and Timber Sub (Filed With SEC on May 22, 2020)
- Offer Letter, dated March 31, 2020, between Joseph Lucchese and Timber Sub (Filed With SEC on May 22, 2020)
- Form of Indemnification Agreement (Filed With SEC on May 22, 2020)
- Amendment No. 2 to Agreement and Plan of Merger, dated April 27, 2020, among BioPharmX, Timber and Merger Sub (Filed With SEC on April 27, 2020)
- Form of Amendment No. 1 to Securities Purchase Agreement, dated April 27, 2020, by and among Timber, BioPharmX and certain investors parties thereto (Filed With SEC on April 27, 2020)
- Description of Capital Stock (Filed With SEC on March 23, 2020)
- Asset Acquisition Agreement, dated February 28, 2019, by and among Timber, Patagonia, Johnathan Rome and Zachary Rome (Filed With SEC on February 20, 2020)
- Offer Letter, dated June 20, 2019, between John Koconis and Timber (Filed With SEC on February 20, 2020)
- Asset Acquisition Agreement, dated June 26, 2019, by and among Timber, Patagonia, Jonathan Rome and Zachary Rome (Filed With SEC on February 20, 2020)
- License Agreement, dated July 5, 2019, by and between AFT and Timber (Filed With SEC on February 20, 2020)
- Management Services Agreement, dated January 1, 2020, by and between TardiMed and Timber (Filed With SEC on February 20, 2020)
- Consulting Services Agreement, dated January 8, 2020, by and between Timber Pharmaceuticals, LLC and AT Consulting LLC (Filed With SEC on February 20, 2020)
- Sublease Agreement between BioPharmX, Inc. and Full Cycle Bioplastics Inc., dated February 14, 2020 (Filed With SEC on February 18, 2020)
- Bridge Warrant To Purchase Common Stock, dated January 28, 2020, made by BioPharmX in favor of Timber (Filed With SEC on January 29, 2020)
- Bridge Loan Credit Agreement, dated January 28, 2020, between BioPharmX and Timber (Filed With SEC on January 29, 2020)
- Note, dated January 28, 2020, made by BioPharmX in favor of Timber (Filed With SEC on January 29, 2020)
- Form of Stockholder Support Agreement (Filed With SEC on January 29, 2020)
- Form of Exchange Agreement, dated January 28, 2020, between BioPharmX and the Holders (Filed With SEC on January 29, 2020)
- Agreement and Plan of Merger and Reorganization, dated January 28, 2020, among BioPharmX, Timber and Merger Sub (Filed With SEC on January 29, 2020)
- Consulting Agreement between Kin Chan and BioPharmX, Inc., as amended (Filed With SEC on September 9, 2019)
- Offer Letter between Steven Bosacki and the Company, effective as of July 16, 2019 (Filed With SEC on July 17, 2019)
- Capital on DemandTM Sales Agreement, dated May 16, 2019, by and between BioPharmX Corporation and JonesTrading Institutional Services LLC (Filed With SEC on May 16, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on March 21, 2019)
- Placement Agency Agreement (Filed With SEC on March 21, 2019)
- Form of Warrant (Filed With SEC on December 7, 2018)
- Form of New Warrant (Filed With SEC on November 21, 2018)
- Form of Warrant Exercise Agreement (Filed With SEC on November 21, 2018)
- Lease agreement between BioPharmX, Inc. and The Irvine Company LLC, dated October 30, 2018 (Filed With SEC on October 31, 2018)
- Offer Letter between David Tierney and the Company, effective as of September 11, 2018 (Filed With SEC on September 13, 2018)
- First Amendment to Sublease Agreement entered into on September 25, 2017 between BioPharmX, Inc. and Refuge Biotechnologies, Inc (Filed With SEC on December 12, 2017)
- Form of Pre-funded Warrant (Filed With SEC on November 27, 2017)
- Form of Series A Common Warrant (Filed With SEC on November 27, 2017)
- Form of Series B Common Warrant (Filed With SEC on November 27, 2017)
- Form of Representatives Warrant (Filed With SEC on November 27, 2017)
- Form of Series B Common Warrant (Filed With SEC on November 20, 2017)
- Form of underwriting agreement (Filed With SEC on November 17, 2017)
- Form of Representative's Warrant (Filed With SEC on November 17, 2017)
- Form of Series A Common Warrant (Filed With SEC on November 17, 2017)
- Form of Pre-funded Warrant (Filed With SEC on November 17, 2017)
- Form of Series B Common Warrant (Filed With SEC on November 17, 2017)
- Form of underwriting agreement (Filed With SEC on November 9, 2017)
- Form of Representative's Warrant (Filed With SEC on November 9, 2017)
- Form of Warrant (Filed With SEC on November 9, 2017)
- Form of New Warrant (Filed With SEC on October 23, 2017)
- Form of Warrant Exercise Agreement (Filed With SEC on October 23, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 24, 2017)
- AMENDMENT TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 14, 2017)
- EXHIBIT A COMMON STOCK PURCHASE WARRANT biopharmx corporation (Filed With SEC on April 26, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 26, 2017)
- roth capital partners, llc 888 San Clemente Drive, Newport Beach, CA 92660 | 800 ###-###-#### | www.roth.com | Member SIPC/FINRA (Filed With SEC on April 26, 2017)
- BIOPHARMX CORPORATION 2016 EQUITY INCENTIVE PLAN (adopted by the Board on February 10, 2017) (amended and restated on March 28, 2017) (Filed With SEC on April 21, 2017)
- BIOPHARMX CORPORATION EMPLOYMENT AGREEMENT (Filed With SEC on April 21, 2017)
- SUBLEASE (Filed With SEC on December 19, 2016)
- 31,489,429 Shares of Common Stock 1,515 Shares of Series A Convertible Preferred Stock (Convertible Into 4,328,571 Shares of Common Stock) Warrants to Purchase 26,863,501 Shares... (Filed With SEC on November 22, 2016)
- BIOPHARMX CORPORATION WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on November 22, 2016)
- BIOPHARMX CORPORATION WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on November 4, 2016)
- FORM OF UNDERWRITER WARRANT (Filed With SEC on November 4, 2016)
- ASSIGNMENT AND ACCEPTANCE (Filed With SEC on October 14, 2016)
- BIOPHARMX CORPORATION SECURED CONVERTIBLE PROMISSORY NOTE Note No.: 201603 $964,852 Made as of September 8, 2016 (Filed With SEC on October 14, 2016)
- BIOPHARMX CORPORATION SECURED CONVERTIBLE PROMISSORY NOTE Note No.: 201604 $35,148 Made as of September 8, 2016 (Filed With SEC on October 14, 2016)
- COMMON STOCK PURCHASE WARRANT BIOPHARMX CORPORATION (Filed With SEC on September 27, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 27, 2016)
- 430 Park Avenue | New York, New York 10022 | 212 ###-###-#### Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC (Filed With SEC on September 27, 2016)
- STANDSTILL AGREEMENT (Filed With SEC on August 18, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 18, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 18, 2016)
- FORM OF REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 18, 2016)
- PURCHASE AGREEMENT (Filed With SEC on August 18, 2016)
- BIOPHARMX CORPORATION 1098 Hamilton Court Menlo Park, California 94025 (Filed With SEC on August 18, 2016)
- SUBSCRIPTION AGREEMENT (Filed With SEC on August 18, 2016)
- SECURITY AGREEMENT (Filed With SEC on August 18, 2016)
- SUBSCRIPTION AGREEMENT (Filed With SEC on August 18, 2016)
- BIOPHARMX CORPORATION SUBSCRIPTION AGREEMENT (Filed With SEC on May 2, 2016)
- INVESTOR RIGHTS AGREEMENT (Filed With SEC on May 2, 2016)
- BIOPHARMX CORPORATION UNDERWRITING AGREEMENT (Filed With SEC on March 29, 2016)
- FORM OF COMMON STOCK PURCHASE WARRANT BIOPHARMX CORPORATION (Filed With SEC on March 29, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 11, 2015)
- 1098 Hamilton Court Menlo Park, CA 94025 T: 650 ###-###-#### F: 650 ###-###-#### www.biopharmx.com (Filed With SEC on September 14, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on September 14, 2015)
- BIOPHARMX, INC. NOTICE OF INDUCEMENT OPTION GRANT (Filed With SEC on September 14, 2015)
- 3,636,364 Shares of Common Stock BioPharmX Corporation UNDERWRITING AGREEMENT (Filed With SEC on June 26, 2015)
- BIOPHARMX CORPORATION FORM OF CONVERTIBLE PROMISSORY NOTE (Filed With SEC on June 19, 2015)
- [ ] Shares of Common Stock BioPharmX Corporation FORM OF UNDERWRITING AGREEMENT (Filed With SEC on June 1, 2015)
- Form of Underwriters Warrant Agreement (Filed With SEC on June 1, 2015)
- [ ] Shares of Common Stock BioPharmX Corporation FORM OF UNDERWRITING AGREEMENT (Filed With SEC on May 14, 2015)
- AMENDED AND RESTATED DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES A PREFERRED STOCK OF BIOPHARMX CORPORATION (Filed With SEC on May 14, 2015)
- Form of Underwriters Warrant Agreement (Filed With SEC on May 14, 2015)
- FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on May 14, 2015)
- COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on May 14, 2015)
- DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES A PREFERRED STOCK OF BIOPHARMX CORPORATION (Filed With SEC on March 30, 2015)
- CERTIFICATE OF VALIDATION OF CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES A PREFERRED STOCK OF BIOPHARMX CORPORATION Pursuant to Section 204 of the General... (Filed With SEC on March 30, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 30, 2015)
- BIOPHARMX CORPORATION SUBSCRIPTION AGREEMENT (Filed With SEC on March 30, 2015)
- VOTING AGREEMENT (Filed With SEC on November 12, 2014)
- BIOPHARMX CORPORATION SUBSCRIPTION AGREEMENT (Filed With SEC on March 31, 2014)
- INVESTOR RIGHTS AGREEMENT (Filed With SEC on March 31, 2014)
- SHARE EXCHANGE AGREEMENT (Filed With SEC on January 27, 2014)
- 6% SECURED CONVERTIBLE PROMISSORY NOTE BIOPHARMX INC. DUE ___________ (Filed With SEC on January 27, 2014)
- COMMON STOCK PURCHASE WARRANT (Filed With SEC on January 27, 2014)
- STOCK PURCHASE AGREEMENT (Filed With SEC on January 27, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on January 27, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on January 27, 2014)
- THOMPSON DESIGNS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on January 27, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 27, 2014)
- AMENDMENT AGREEMENT (Filed With SEC on January 27, 2014)
- SECURITY AGREEMENT (Filed With SEC on January 27, 2014)
- Promissory Note dated December 21, 2012 (Filed With SEC on December 31, 2012)
